Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Risk factors for acute decompensation of chronic kidney disease in hospitalized patients in the nephrology department: a case-control study.

Mahmoud LB, Pariente A, Kammoun K, Hakim A, Ghozzi H, Sahnoun Z, Fourrier A, Hachicha J, Zeghal K.

Clin Nephrol. 2014 Feb;81(2):86-92. doi: 10.5414/CN107948.

PMID:
24219912
2.

Anxious and depressive symptoms in Parkinson's disease: the French cross-sectionnal DoPaMiP study.

Nègre-Pagès L, Grandjean H, Lapeyre-Mestre M, Montastruc JL, Fourrier A, Lépine JP, Rascol O; DoPaMiP Study Group.

Mov Disord. 2010 Jan 30;25(2):157-66. doi: 10.1002/mds.22760.

PMID:
19950403
3.

Inappropriate medication use and risk of falls--a prospective study in a large community-dwelling elderly cohort.

Berdot S, Bertrand M, Dartigues JF, Fourrier A, Tavernier B, Ritchie K, Alpérovitch A.

BMC Geriatr. 2009 Jul 23;9:30. doi: 10.1186/1471-2318-9-30.

4.

Impact of hospitalisation in an acute medical geriatric unit on potentially inappropriate medication use.

Laroche ML, Charmes JP, Nouaille Y, Fourrier A, Merle L.

Drugs Aging. 2006;23(1):49-59.

PMID:
16492069
5.

Evaluation of statistical association measures for the automatic signal generation in pharmacovigilance.

Roux E, Thiessard F, Fourrier A, Bégaud B, Tubert-Bitter P.

IEEE Trans Inf Technol Biomed. 2005 Dec;9(4):518-27.

PMID:
16379369
6.

Psychiatric disorders and their comorbidity in subjects with parasuicide by intentional drug overdose: prevalence and gender differences.

Tournier M, Molimard M, Cougnard A, Abouelfath A, Fourrier A, Verdoux H.

Psychiatry Res. 2005 Sep 15;136(2-3):93-100.

PMID:
16112202
7.

[Antidepressant adverse effects in the elderly: analysis of spontaneous reports in France].

Daurel-Receveur M, Miremont-Salamé G, Fourrier A, Auriche P, Moore N, Bégaud B, Haramburu F; le réseau des Centres de Pharmacovigilance.

Therapie. 2005 Jan-Feb;60(1):61-5. French.

PMID:
15929475
8.

NSAID use profiles derived from reimbursement data in France.

Moore N, Diris H, Martin K, Viale R, Fourrier A, Moride Y, Bégaud B.

Therapie. 2004 Sep-Oct;59(5):541-6.

PMID:
15648307
9.

Patterns and correlates of benzodiazepine use in the French general population.

Lagnaoui R, Depont F, Fourrier A, Abouelfath A, Bégaud B, Verdoux H, Moore N.

Eur J Clin Pharmacol. 2004 Sep;60(7):523-9.

PMID:
15338086
10.

Differences between clinical trials and postmarketing use.

Martin K, Bégaud B, Latry P, Miremont-Salamé G, Fourrier A, Moore N.

Br J Clin Pharmacol. 2004 Jan;57(1):86-92.

11.

The delusion of reducing sample size.

Bégaud B, Fourrier A, Moore N, Moride Y.

Eur J Clin Pharmacol. 2003 Nov;59(8-9):711-2. Epub 2003 Oct 18. No abstract available.

PMID:
14566441
12.

Does age increase the risk of adverse drug reactions?

Bégaud B, Martin K, Fourrier A, Haramburu F.

Br J Clin Pharmacol. 2002 Nov;54(5):550-2. No abstract available.

13.

Hepatitis B vaccination and first central nervous system demyelinating event: a case-control study.

Touzé E, Fourrier A, Rue-Fenouche C, Rondé-Oustau V, Jeantaud I, Bégaud B, Alpérovitch A.

Neuroepidemiology. 2002 Jul-Aug;21(4):180-6.

PMID:
12065880
14.

Benzodiazepine use and risk of dementia: a nested case-control study.

Lagnaoui R, Bégaud B, Moore N, Chaslerie A, Fourrier A, Letenneur L, Dartigues JF, Moride Y.

J Clin Epidemiol. 2002 Mar;55(3):314-8.

PMID:
11864804

Supplemental Content

Loading ...
Support Center